by Gemma Escarré,
Dr Jordi Mestres, founder and CEO of CataloniaBio & HealthTech member Chemotargets and coordinator of the Systems Pharmacology Group at the Hospital del Mar Research Institute (IMIM), has been admitted as a fellow of the Royal Society of Chemistry.
This recognition, one of the most important granted to a chemist, is an important milestone in a researcher's career because it is indicative of scientific quality.
The Royal Society of Chemistry has more than 54,000 members around the world and heritage spanning over 175 years. Its mission is to advance the chemical sciences by investing in educating future generations of scientists, promoting innovation and advising governments.
Chemotargets was founded in 2006 and is based at the Barcelona Science Park (PCB).
Photo: Jordi Mestres - IMIM / Josep Cano